Abivax (ABVX) Exchange Rate Effect (2024 - 2026)
Abivax (ABVX) recorded quarterly Exchange Rate Effect of $8.7 million in Q1 2026, up 648.36% quarter-over-quarter from -$1.6 million in Q4 2025, and up 1278.98% on a YoY basis from $629527.5 in Q1 2025.
Abivax (ABVX) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Abivax's Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $8.7 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 1278.98% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at -$2.5 million (down 783.37% YoY), while the FY2025 annual figure was -$12.0 million, down 567.5% from the prior year.
- Exchange Rate Effect was $8.7 million for Q1 2026 at Abivax, up from -$1.6 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $8.7 million in Q1 2026 to a low of -$8.4 million in Q3 2025.
- Historically, Exchange Rate Effect has averaged -$77422.5 across 3 years, with a median of -$736319.1 in 2025.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect slumped 352.88% in 2025, then surged 1278.98% in 2026.
- A 3-year view of Exchange Rate Effect shows it stood at $2.7 million in 2024, then slumped by 157.62% to -$1.6 million in 2025, then jumped by 648.36% to $8.7 million in 2026.
- The last three Exchange Rate Effect figures came in at $8.7 million (Q1 2026), -$1.6 million (Q4 2025), and -$8.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | -900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Mn |
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | -1.58 Mn |
| Dec 31, 2025 | -1.58 Mn |
| Sep 30, 2025 | -8.36 Mn |
| Sep 30, 2025 | -8.36 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -736,319.11 |
| Mar 31, 2025 | -736,319.11 |
| Dec 31, 2024 | 2.75 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | 485,676.30 |
| Jun 30, 2024 | 485,676.30 |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |